Currently, it is generally believed that a Ki-67 cut-off level of 5% can help distinguish benign parathyroid tumors from PCs, but the 2022 WHO classification does not consider the proliferation index as a diagnostic criterion for PC [37]. Here, MKI67 is linked to benign neoplasm of parathyroid gland.